{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:08:35Z","timestamp":1794028115456,"version":"4.8.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T00:00:00Z","timestamp":1722297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Swiss Federal Institute of Technology Zurich"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Patient Saf Surg"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>A growing number of countries have reported sharp increases in the use and harm of opioid analgesics. High rates of new opioid initiation are observed in postoperative patients. In response, various tertiary care institutions have developed opioid exit plans (OEPs) to curb potential opioid-related harm.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>PubMed and Embase were systematically searched to identify, summarize, and compare the interventional elements of OEPs for postoperative patient populations published from January 1, 2000, to June 4, 2024. Two researchers independently screened the articles for eligibility following the PRISMA 2020 guidelines, extracted the data, and assessed the study quality and risk of bias. Data synthesis was performed for study characteristics, intervention details, efficacy, and development.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 2,585 articles were screened, eight of which met the eligibility criteria. All studies were conducted in North America and focused on orthopedic surgery patients following total hip or knee arthroplasty (n\u2009=\u20095) or neurosurgery (n\u2009=\u20093). Most studies (n\u2009=\u20097) included a pre-post (n\u2009=\u20094) or randomized clinical design (n\u2009=\u20093). Three studies were of good quality, and none had a low risk of bias. The interventions varied and ranged from educational sessions (n\u2009=\u20091) to individualized tapering protocols (n\u2009=\u20094) or a combination of the two (n\u2009=\u20092). Key elements were instructions on how to anticipate patients\u2019 postoperative need for opioid analgesics and tapering strategies based on 24-h predischarge opioid consumption. Six studies included efficacy as an endpoint in their analysis, of which four assessed statistical significance, with all four identifying that the OEPs were successful in reducing postoperative opioid use.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Despite differences in design and implementation, the identified OEPs suggest that they are efficacious in reducing outpatient opioid consumption. They provide a robust estimate of postoperative analgesic requirements and a rationale for tapering duration and rate. However, more rigorous studies are needed to evaluate their real-world effectiveness.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13037-024-00408-w","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T18:03:05Z","timestamp":1722362585000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Opioid exit plans for tapering postoperative pain control in noncancer patients: a systematic review"],"prefix":"10.1186","volume":"18","author":[{"given":"Marcel","family":"Rainer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Maleika","family":"Ommerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Michelle","family":"Burden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Betschart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"St\u00e4mpfli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,30]]},"reference":[{"key":"408_CR1","doi-asserted-by":"crossref","unstructured":"Spencer M, Mini\u00f1o A, Warner M. Drug Overdose Deaths in the United States, 2001\u20132021 [Internet]. National Center for Health Statistics (U.S.); 2022 [cited 2023 Oct 24]. Available from: https:\/\/stacks.cdc.gov\/view\/cdc\/122556","DOI":"10.15620\/cdc:122556"},{"key":"408_CR2","unstructured":"Understanding the Opioid Overdose Epidemic [Internet]. Center for Disease Control and Prevention; 2021 [cited 2023 Oct 24]. Available from: https:\/\/www.cdc.gov\/opioids\/basics\/epidemic.html"},{"issue":"12","key":"408_CR3","doi-asserted-by":"publisher","first-page":"e0278508","DOI":"10.1371\/journal.pone.0278508","volume":"17","author":"T Gomes","year":"2022","unstructured":"Gomes T, Men S, Campbell TJ, Tadrous M, Mamdani MM, Paterson JM, et al. Changing patterns of opioid initiation for pain management in Ontario, Canada: A population-based cross-sectional study. Chen RJ, editor. PLOS ONE. 2022;17(12):e0278508.","journal-title":"PLOS ONE."},{"issue":"5","key":"408_CR4","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1016\/j.amepre.2018.06.008","volume":"55","author":"GP Guy","year":"2018","unstructured":"Guy GP, Zhang K. Opioid prescribing by specialty and volume in the US. Am J Prev Med. 2018;55(5):e153\u20135.","journal-title":"Am J Prev Med."},{"issue":"3","key":"408_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.amepre.2015.02.020","volume":"49","author":"B Levy","year":"2015","unstructured":"Levy B, Paulozzi L, Mack KA, Jones CM. Trends in opioid analgesic-prescribing rates by specialty, U.S., 2007\u20132012. Am J Prev Med. 2015;49(3):409\u201313.","journal-title":"Am J Prev Med."},{"key":"408_CR6","unstructured":"Regueras Escudero E, L\u00f3pez Guzm\u00e1n J. Prescriptions of opioid medicines in Spain between 2019 and 2020: what medical specialities are prescribing them and in what indications. Multidiscipl Pain J. 2021 [cited 2024 Jan 22]; Available from: https:\/\/www.mpainjournal.com\/Documentos\/ArticulosNew\/01-Art-6-ING_3_1.pdf"},{"key":"408_CR7","doi-asserted-by":"publisher","first-page":"l6968","DOI":"10.1136\/bmj.l6968","volume":"29","author":"MV Kiang","year":"2020","unstructured":"Kiang MV, Humphreys K, Cullen MR, Basu S. Opioid prescribing patterns among medical providers in the United States, 2003\u201317: retrospective, observational study. BMJ. 2020;29:l6968.","journal-title":"BMJ"},{"issue":"4","key":"408_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1155\/2014\/857952","volume":"19","author":"C Ringwalt","year":"2014","unstructured":"Ringwalt C, Gugelmann H, Garrettson M, Dasgupta N, Chung AE, Proescholdbell SK, et al. Differential prescribing of opioid analgesics according to physician specialty for medicaid patients with chronic noncancer pain diagnoses. Pain Res Manag. 2014;19(4):179\u201385.","journal-title":"Pain Res Manag"},{"issue":"5","key":"408_CR9","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/pm\/pnx027","volume":"19","author":"SG Weiner","year":"2018","unstructured":"Weiner SG, Baker O, Rodgers AF, Garner C, Nelson LS, Kreiner PW, et al. Opioid prescriptions by specialty in Ohio, 2010\u20132014. Pain Med. 2018;19(5):978\u201389.","journal-title":"Pain Med"},{"issue":"1","key":"408_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ejp.1291","volume":"23","author":"C Chenaf","year":"2019","unstructured":"Chenaf C, Kabor\u00e9 JL, Delorme J, Pereira B, Mulliez A, Zenut M, et al. Prescription opioid analgesic use in France: trends and impact on morbidity-mortality. Eur J Pain. 2019;23(1):124\u201334.","journal-title":"Eur J Pain"},{"key":"408_CR11","doi-asserted-by":"crossref","unstructured":"Schubert I, Ihle P, Sabatowski R. Increase in Opiate Prescription in Germany Between 2000 and 2010. Dtsch \u00c4rztebl Int. 2013 [cited 2024 Jan 19]; Available from: https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2013.0045","DOI":"10.3238\/arztebl.2013.0045"},{"key":"408_CR12","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.2147\/JPR.S163438","volume":"11","author":"UM Musazzi","year":"2018","unstructured":"Musazzi UM, Rocco P, Brunelli C, Bisaglia L, Caraceni A, Minghetti P. Do laws impact opioids consumption? A breakpoint analysis based on Italian sales data. J Pain Res. 2018;11:1665\u201372.","journal-title":"J Pain Res"},{"issue":"4","key":"408_CR13","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1007\/s11096-017-0492-9","volume":"39","author":"FN Wagemaakers","year":"2017","unstructured":"Wagemaakers FN, Hollingworth SA, Kreijkamp-Kaspers S, Tee EHL, Leendertse AJ, Van Driel ML. Opioid analgesic use in Australia and The Netherlands: a cross-country comparison. Int J Clin Pharm. 2017;39(4):874\u201380.","journal-title":"Int J Clin Pharm"},{"issue":"10","key":"408_CR14","doi-asserted-by":"publisher","first-page":"e498","DOI":"10.1016\/S2468-2667(19)30128-8","volume":"4","author":"GA Kalkman","year":"2019","unstructured":"Kalkman GA, Kramers C, Van Dongen RT, Van Den Brink W, Schellekens A. Trends in use and misuse of opioids in the Netherlands: a retrospective, multi-source database study. Lancet Public Health. 2019;4(10):e498\u2013505.","journal-title":"Lancet Public Health"},{"issue":"3","key":"408_CR15","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00520-016-3460-3","volume":"25","author":"T Dzier\u017canowski","year":"2017","unstructured":"Dzier\u017canowski T, Cia\u0142kowska-Rysz A. Accessibility of opioid analgesics and barriers to optimal chronic pain treatment in Poland in 2000\u20132015. Support Care Cancer. 2017;25(3):775\u201381.","journal-title":"Support Care Cancer"},{"key":"408_CR16","unstructured":"Agencia Espanola de Medicamentos y Productos Sanitarios. Utilizaci\u00f3n de medicamentos opioides en Espa\u00f1a durante el periodo 2008\u20132015 [Internet]. 2017 Feb [cited 2024 Jan 19] p. 3. (Informe De Utilizaci\u00f3n De Medicamentos). Report No.: U\/OPI\/V1\/13022017. Available from: https:\/\/www.aemps.gob.es\/medicamentosUsoHumano\/observatorio\/docs\/opioides-2008-2015.pdf"},{"issue":"10","key":"408_CR17","doi-asserted-by":"publisher","first-page":"e1003270","DOI":"10.1371\/journal.pmed.1003270","volume":"17","author":"M Jani","year":"2020","unstructured":"Jani M, Birlie Yimer B, Sheppard T, Lunt M, Dixon WG. Time trends and prescribing patterns of opioid drugs in UK primary care patients with non-cancer pain: A retrospective cohort study. Song Z, editor. PLOS Med. 2020;17(10):e1003270.","journal-title":"PLOS Med."},{"issue":"4","key":"408_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s40801-019-00163-w","volume":"6","author":"SK Nissen","year":"2019","unstructured":"Nissen SK, Potteg\u00e5rd A, Ryg J. Trends of opioid utilisation in Denmark: a nationwide study. Drugs - Real World Outcomes. 2019;6(4):155\u201364.","journal-title":"Drugs - Real World Outcomes"},{"issue":"9","key":"408_CR19","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/j.1532-2149.2014.496.x","volume":"18","author":"CS Zin","year":"2014","unstructured":"Zin CS, Chen L-C, Knaggs RD. Changes in trends and pattern of strong opioid prescribing in primary care. Eur J Pain. 2014;18(9):1343\u201351.","journal-title":"Eur J Pain"},{"issue":"1","key":"408_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12913-017-2086-6","volume":"17","author":"MM Wertli","year":"2017","unstructured":"Wertli MM, Reich O, Signorell A, Burgstaller JM, Steurer J, Held U. Changes over time in prescription practices of pain medications in Switzerland between 2006 and 2013: an analysis of insurance claims. BMC Health Serv Res. 2017;17(1):167.","journal-title":"BMC Health Serv Res"},{"issue":"12","key":"408_CR21","doi-asserted-by":"publisher","first-page":"732345","DOI":"10.3389\/fphar.2021.732345","volume":"14","author":"A Kurdi","year":"2021","unstructured":"Kurdi A. Opioids and gabapentinoids utilisation and their related-mortality trends in the United Kingdom primary care setting, 2010\u20132019: a cross-national, population-based comparison study. Front Pharmacol. 2021;14(12):732345.","journal-title":"Front Pharmacol"},{"issue":"9","key":"408_CR22","doi-asserted-by":"publisher","first-page":"e0238285","DOI":"10.1371\/journal.pone.0238285","volume":"15","author":"JM Burgstaller","year":"2020","unstructured":"Burgstaller JM, Held U, Signorell A, Blozik E, Steurer J, Wertli MM. Increased risk of adverse events in non-cancer patients with chronic and high-dose opioid use\u2014A health insurance claims analysis. Suppiah V, editor. PLOS ONE. 2020;15(9):e0238285.","journal-title":"PLOS ONE."},{"key":"408_CR23","doi-asserted-by":"publisher","first-page":"103785","DOI":"10.1016\/j.drugpo.2022.103785","volume":"108","author":"L Gjersing","year":"2022","unstructured":"Gjersing L, Amundsen E. Increasing trend in accidental pharmaceutical opioid overdose deaths and diverging overdose death correlates following the opioid prescription policy liberalization in Norway 2010\u20132018. Int J Drug Policy. 2022;108:103785.","journal-title":"Int J Drug Policy"},{"key":"408_CR24","doi-asserted-by":"publisher","first-page":"100437","DOI":"10.1016\/j.lanepe.2022.100437","volume":"20","author":"MF Hooijman","year":"2022","unstructured":"Hooijman MF, Martinez-De La Torre A, Weiler S, Burden AM. Opioid sales and opioid-related poisonings in Switzerland: A descriptive population-based time-series analysis. Lancet Reg Health - Eur. 2022;20:100437.","journal-title":"Lancet Reg Health - Eur."},{"key":"408_CR25","unstructured":"Bickel W, Stitzer M, Liebson I, Bigelow GE. Acute physical dependence in man: Effects of naloxone after brief morphine exposure. J Pharmacol Experiment Therapeut. 1988;244(1):126\u201332."},{"issue":"4","key":"408_CR26","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/BF02244902","volume":"112","author":"KC Kirby","year":"1993","unstructured":"Kirby KC, Stitzer ML. Opioid physical dependence development in humans: effect of time between agonist pretreatments. Psychopharmacology. 1993;112(4):511\u20137.","journal-title":"Psychopharmacology"},{"key":"408_CR27","unstructured":"Heishman S, Stitzer M, Bigelow G, Liebson I. Acute opioid physical dependence in humans: Effect of varying the morphine-naloxone interval. J Pharmacol Experiment Therapeut. 1989;250(2):485\u201391."},{"issue":"1","key":"408_CR28","first-page":"1","volume":"45","author":"F Sandbrink","year":"2019","unstructured":"Sandbrink F, Uppal R. The time for opioid stewardship is now. Jt Comm J Qual Patient Saf. 2019;45(1):1\u20132.","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"408_CR29","first-page":"100557","volume":"23","author":"The Lancet Regional Health \u2013 Americas","year":"2023","unstructured":"The Lancet Regional Health \u2013 Americas. Opioid crisis: addiction, overprescription, and insufficient primary prevention. Lancet Reg Health - Am. 2023;23:100557.","journal-title":"Lancet Reg Health - Am"},{"issue":"9","key":"408_CR30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.5694\/mja2.50818","volume":"213","author":"SA Schug","year":"2020","unstructured":"Schug SA. Opioid stewardship can reduce inappropriate prescribing of opioids at hospital discharge. Med J Aust. 2020;213(9):409\u201310.","journal-title":"Med J Aust"},{"key":"408_CR31","doi-asserted-by":"crossref","unstructured":"Michalowski A, Boateng S, Fraser MR, Levine RL. Developing a Culture of Opioid Stewardship: The Pennsylvania Example. In: A public health guide to ending the opioid epidemic [Internet]. Oxford University Press; 2019 [cited 2024 Mar 14]. p. 307\u201322. Available from: https:\/\/academic.oup.com\/book\/32440\/chapter\/268773901","DOI":"10.1093\/oso\/9780190056810.003.0024"},{"issue":"5","key":"408_CR32","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.surg.2020.01.002","volume":"167","author":"R Khorfan","year":"2020","unstructured":"Khorfan R, Shallcross ML, Yu B, Sanchez N, Parilla S, Coughlin JM, et al. Preoperative patient education and patient preparedness are associated with less postoperative use of opioids. Surgery. 2020;167(5):852\u20138.","journal-title":"Surgery"},{"issue":"3","key":"408_CR33","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.surg.2020.07.047","volume":"169","author":"BS Kushner","year":"2021","unstructured":"Kushner BS, Tan WH, Sehnert M, Jordan K, Aft R, Silviera M, et al. Assessment of postoperative opioid stewardship using a novel electronic-based automated text and phone messaging platform. Surgery. 2021;169(3):660\u20135.","journal-title":"Surgery"},{"issue":"3","key":"408_CR34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/15360288.2020.1734141","volume":"34","author":"EE Coulson","year":"2020","unstructured":"Coulson EE, Kral LA. The Clinical Pharmacist\u2019s Role in Perioperative Surgical Pain Management. J Pain Palliat Care Pharmacother. 2020;34(3):120\u20136.","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"2","key":"408_CR35","doi-asserted-by":"publisher","first-page":"80","DOI":"10.5694\/mja2.52002","volume":"219","author":"AV Langford","year":"2023","unstructured":"Langford AV, Lin CC, Bero L, Blyth FM, Doctor J, Holliday S, et al. Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations. Med J Aust. 2023;219(2):80\u20139.","journal-title":"Med J Aust"},{"issue":"3","key":"408_CR36","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/j.pain.0000000000002746","volume":"164","author":"M Hamilton","year":"2023","unstructured":"Hamilton M, Kwok WS, Hsu A, Mathieson S, Gnjidic D, Deyo R, et al. Opioid deprescribing in patients with chronic noncancer pain: a systematic review of international guidelines. Pain. 2023;164(3):485\u201393.","journal-title":"Pain"},{"issue":"11","key":"408_CR37","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1097\/j.pain.0000000000002271","volume":"162","author":"MD Sullivan","year":"2021","unstructured":"Sullivan MD. Opioid deprescribing guidelines and consumer preferences: betwixt and between. Pain. 2021;162(11):2625\u20136.","journal-title":"Pain"},{"issue":"3","key":"408_CR38","doi-asserted-by":"publisher","first-page":"e201129","DOI":"10.1001\/jamanetworkopen.2020.1129","volume":"3","author":"LS Nelson","year":"2020","unstructured":"Nelson LS, Mazer-Amirshahi M, Perrone J. Opioid Deprescribing in Emergency Medicine\u2014A Tool in an Expanding Toolkit. JAMA Netw Open. 2020;3(3):e201129.","journal-title":"JAMA Netw Open"},{"key":"408_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jclinepi.2021.02.003","volume":"134","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. J Clin Epidemiol. 2021;134:103\u201312.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"408_CR40","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1108\/07378830610692127","volume":"24","author":"A Booth","year":"2006","unstructured":"Booth A. Clear and present questions: formulating questions for evidence based practice. Cleyle S, editor. Libr Hi Tech. 2006;24(3):355\u201368.","journal-title":"Libr Hi Tech."},{"issue":"10","key":"408_CR41","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","volume":"18","author":"MDJ Peters","year":"2020","unstructured":"Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth. 2020;18(10):2119\u201326.","journal-title":"JBI Evid Synth"},{"issue":"1","key":"408_CR42","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.","journal-title":"Syst Rev"},{"key":"408_CR43","unstructured":"Cochrane Effective Practice and Organisation of Care (EPOC), editor. Good practice data extraction form, EPOC resources for review authors, 2017 [Internet]. epoc.cochrane.org\/epoc-resources-review-authors; [cited 2023 Jun 20]. Available from: https:\/\/epoc.cochrane.org\/sites\/epoc.cochrane.org\/files\/public\/uploads\/Resources-for-authors2017\/good_practice_data_extraction_form.doc"},{"issue":"6","key":"408_CR44","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/j.1365-2753.2009.01314.x","volume":"15","author":"E Clark","year":"2009","unstructured":"Clark E, Burkett K, Stanko-Lopp D. Let Evidence Guide Every New Decision (LEGEND): an evidence evaluation system for point-of-care clinicians and guideline development teams. J Eval Clin Pract. 2009;15(6):1054\u201360.","journal-title":"J Eval Clin Pract"},{"key":"408_CR45","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"28","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;28:l4898.","journal-title":"BMJ"},{"key":"408_CR46","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"12","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;12:i4919.","journal-title":"BMJ"},{"issue":"2","key":"408_CR47","doi-asserted-by":"publisher","first-page":"e1230","DOI":"10.1002\/cl2.1230","volume":"18","author":"NR Haddaway","year":"2022","unstructured":"Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis. Campbell Syst Rev. 2022;18(2):e1230.","journal-title":"Campbell Syst Rev"},{"issue":"2","key":"408_CR48","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.pmn.2021.08.001","volume":"23","author":"M B\u00e9rub\u00e9","year":"2022","unstructured":"B\u00e9rub\u00e9 M, Dupuis S, Leduc S, Roy I, Turcotte V, C\u00f4t\u00e9 C, et al. Tapering opioid prescription program for high-risk trauma patients: a pilot randomized controlled trial. Pain Manag Nurs. 2022;23(2):142\u201350.","journal-title":"Pain Manag Nurs"},{"key":"408_CR49","doi-asserted-by":"publisher","first-page":"100596","DOI":"10.1016\/j.eclinm.2020.100596","volume":"28","author":"JM Hah","year":"2020","unstructured":"Hah JM, Trafton JA, Narasimhan B, Krishnamurthy P, Hilmoe H, Sharifzadeh Y, et al. Efficacy of motivational-interviewing and guided opioid tapering support for patients undergoing orthopedic surgery (MI-Opioid Taper): A prospective, assessor-blind, randomized controlled pilot trial. EClinicalMedicine. 2020;28:100596.","journal-title":"EClinicalMedicine"},{"issue":"4","key":"408_CR50","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/BCO.0000000000000632","volume":"29","author":"S Singh","year":"2018","unstructured":"Singh S, Clarke C, Lawendy AR, Macleod M, Sanders D, Tieszer C. First Place: A prospective, randomized controlled trial of the impact of written discharge instructions for postoperative opioids on patient pain satisfaction and on minimizing opioid risk exposure in orthopaedic surgery. Curr Orthop Pract. 2018;29(4):292\u20136.","journal-title":"Curr Orthop Pract"},{"issue":"7","key":"408_CR51","doi-asserted-by":"publisher","first-page":"e304","DOI":"10.5435\/JAAOS-D-19-00030","volume":"28","author":"EY Chen","year":"2020","unstructured":"Chen EY, Betancourt L, Li L, Trucks E, Marcantonio A, Tornetta P. Standardized, patient-specific, postoperative opioid prescribing after inpatient orthopaedic surgery. J Am Acad Orthop Surg. 2020;28(7):e304\u201318.","journal-title":"J Am Acad Orthop Surg"},{"issue":"2","key":"408_CR52","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1016\/j.japh.2017.01.016","volume":"57","author":"C Genord","year":"2017","unstructured":"Genord C, Frost T, Eid D. Opioid exit plan: A pharmacist\u2019s role in managing acute postoperative pain. J Am Pharm Assoc. 2017;57(2):S92\u20138.","journal-title":"J Am Pharm Assoc"},{"issue":"6","key":"408_CR53","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1136\/rapm-2020-101324","volume":"45","author":"SS Joo","year":"2020","unstructured":"Joo SS, Hunter OO, Tamboli M, Leng JC, Harrison TK, Kassab K, et al. Implementation of a patient-specific tapering protocol at discharge decreases total opioid dose prescribed for 6 weeks after elective primary spine surgery. Reg Anesth Pain Med. 2020;45(6):474\u20138.","journal-title":"Reg Anesth Pain Med"},{"issue":"2","key":"408_CR54","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.arth.2022.08.043","volume":"38","author":"VV Kukushliev","year":"2023","unstructured":"Kukushliev VV, Sherman KA, Kurylo CM, Ortmann SD, Scheidt RA, Scheidt KB. Tapered dose postoperative opioid prescriptions following inpatient total hip and knee arthroplasty: quality improvement study and retrospective review. J Arthroplasty. 2023;38(2):239\u201344.","journal-title":"J Arthroplasty"},{"issue":"7","key":"408_CR55","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/pm\/pnz260","volume":"21","author":"M Tamboli","year":"2020","unstructured":"Tamboli M, Mariano ER, Gustafson KE, Briones BL, Hunter OO, Wang RR, et al. A multidisciplinary patient-specific opioid prescribing and tapering protocol is associated with a decrease in total opioid dose prescribed for six weeks after total hip arthroplasty. Pain Med. 2020;21(7):1474\u201381.","journal-title":"Pain Med"},{"key":"408_CR56","unstructured":"McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods [Internet]. n\/a(n\/a). Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/jrsm.1411"},{"issue":"1","key":"408_CR57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s40814-019-0444-3","volume":"5","author":"M B\u00e9rub\u00e9","year":"2019","unstructured":"B\u00e9rub\u00e9 M, Deslauriers V, Leduc S, Turcotte V, Dupuis S, Roy I, et al. Feasibility of a tapering opioids prescription program for trauma patients at high risk of chronic consumption (TOPP-trauma): protocol for a pilot randomized controlled trial. Pilot Feasibility Stud. 2019;5(1):67.","journal-title":"Pilot Feasibility Stud"},{"key":"408_CR58","unstructured":"Royal College of Physicians. Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults [Internet]. National Institute for Health and Care Excellence; 2022. Available from: https:\/\/www.nice.org.uk\/guidance\/ng215\/chapter\/Recommendations#reviewing-a-dependence-forming-medicine-or-antidepressant"},{"issue":"3","key":"408_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","volume":"71","author":"D Dowell","year":"2022","unstructured":"Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical practice guideline for prescribing opioids for pain \u2014 United States, 2022. MMWR Recomm Rep. 2022;71(3):1\u201395.","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"408_CR60","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1177\/0310057X1704500609","volume":"45","author":"N Stark","year":"2017","unstructured":"Stark N, Kerr S, Stevens J. Prevalence and predictors of persistent post-surgical opioid use: a prospective observational cohort study. Anaesth Intensive Care. 2017;45(6):700\u20136.","journal-title":"Anaesth Intensive Care"},{"issue":"6","key":"408_CR61","doi-asserted-by":"publisher","first-page":"e207367","DOI":"10.1001\/jamanetworkopen.2020.7367","volume":"3","author":"OD Lawal","year":"2020","unstructured":"Lawal OD, Gold J, Murthy A, Ruchi R, Bavry E, Hume AL, et al. Rate and risk factors associated with prolonged opioid use after surgery: a systematic review and meta-analysis. JAMA Netw Open. 2020;3(6):e207367.","journal-title":"JAMA Netw Open"},{"issue":"15","key":"408_CR62","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.2106\/JBJS.17.01239","volume":"100","author":"A Mohamadi","year":"2018","unstructured":"Mohamadi A, Chan JJ, Lian J, Wright CL, Marin AM, Rodriguez EK, et al. Risk factors and pooled rate of prolonged opioid use following trauma or surgery: a systematic review and meta-(regression) analysis. J Bone Jt Surg. 2018;100(15):1332\u201340.","journal-title":"J Bone Jt Surg"},{"issue":"10","key":"408_CR63","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/aas.14139","volume":"66","author":"E Lappalainen","year":"2022","unstructured":"Lappalainen E, Ruohoaho U, Kokki H, Aaltomaa S, Anttila M, Gissler M, et al. Postoperative pain in a prospectively assessed surgical short-stay cohort: a subgroup analysis. Acta Anaesthesiol Scand. 2022;66(10):1193\u2013201.","journal-title":"Acta Anaesthesiol Scand"},{"key":"408_CR64","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.2147\/JPR.S142889","volume":"10","author":"J Luo","year":"2017","unstructured":"Luo J, Min S. Postoperative pain management in the postanesthesia care unit: an update. J Pain Res. 2017;10:2687\u201398.","journal-title":"J Pain Res"},{"issue":"1","key":"408_CR65","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jamasurg.2017.3132","volume":"153","author":"RE Scully","year":"2018","unstructured":"Scully RE, Schoenfeld AJ, Jiang W, Lipsitz S, Chaudhary MA, Learn PA, et al. Defining optimal length of opioid pain medication prescription after common surgical procedures. JAMA Surg. 2018;153(1):37.","journal-title":"JAMA Surg"},{"issue":"3","key":"408_CR66","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/pds.4929","volume":"29","author":"RN Karmali","year":"2020","unstructured":"Karmali RN, Bush C, Raman SR, Campbell CI, Skinner AC, Roberts AW. Long-term opioid therapy definitions and predictors: A systematic review. Pharmacoepidemiol Drug Saf. 2020;29(3):252\u201369.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"408_CR67","doi-asserted-by":"publisher","first-page":"e053618","DOI":"10.1136\/bmjopen-2021-053618","volume":"11","author":"N Papadomanolakis-Pakis","year":"2021","unstructured":"Papadomanolakis-Pakis N, Haroutounian S, Christiansen CF, Nikolajsen L. Prediction of chronic postsurgical pain in adults: a protocol for multivariable prediction model development. BMJ Open. 2021;11(12):e053618.","journal-title":"BMJ Open"},{"issue":"13","key":"408_CR68","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1001\/jama.2022.16844","volume":"328","author":"A Duong","year":"2022","unstructured":"The NO PAin Investigators, Duong A, Ponniah AK, VanDeCapelle C, Mossuto F, Romeril E, et al. Effect of a postoperative multimodal opioid-sparing protocol vs standard opioid prescribing on postoperative opioid consumption after knee or shoulder arthroscopy: a randomized clinical trial. JAMA. 2022;328(13):1326.","journal-title":"JAMA."},{"key":"408_CR69","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.artd.2020.12.021","volume":"7","author":"K Atwood","year":"2021","unstructured":"Atwood K, Shackleford T, Lemons W, Eicher JL, Lindsey BA, Klein AE. Postdischarge opioid use after total hip and total knee arthroplasty. Arthroplasty Today. 2021;7:126\u20139.","journal-title":"Arthroplasty Today"},{"issue":"1","key":"408_CR70","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13037-022-00346-5","volume":"16","author":"J McLott","year":"2022","unstructured":"McLott J, Stahel PF. Opioid-free anesthesia: the next frontier in surgical patient safety. Patient Saf Surg. 2022;16(1):38 s13037-022-00346\u20135.","journal-title":"Patient Saf Surg."},{"issue":"2","key":"408_CR71","doi-asserted-by":"publisher","first-page":"173","DOI":"10.4103\/sja.sja_341_23","volume":"18","author":"US Rani","year":"2024","unstructured":"Rani US, Panda NB, Chauhan R, Mahajan S, Kaloria N, Tripathi M. Comparison of the effects of opioid-free anesthesia (OFA) and opioid-based anesthesia (OBA) on postoperative analgesia and intraoperative hemodynamics in patients undergoing spine surgery: A prospective randomized double-blind controlled trial. Saudi J Anaesth. 2024;18(2):173\u201380.","journal-title":"Saudi J Anaesth"},{"issue":"2","key":"408_CR72","doi-asserted-by":"publisher","first-page":"109","DOI":"10.17085\/apm.23097","volume":"19","author":"KR Vishnuraj","year":"2024","unstructured":"Vishnuraj KR, Singh K, Sahay N, Sinha C, Kumar A, Kumar N. Opioid-free anesthesia using a combination of ketamine and dexmedetomidine in patients undergoing laparoscopic cholecystectomy: a randomized controlled trial. Anesth Pain Med. 2024;19(2):109\u201316.","journal-title":"Anesth Pain Med."},{"issue":"1","key":"408_CR73","doi-asserted-by":"publisher","first-page":"11759","DOI":"10.1038\/s41598-024-62824-3","volume":"14","author":"Y Hu","year":"2024","unstructured":"Hu Y, Zhang QY, Qin GC, Zhu GH, Long X, Xu JF, et al. Balanced opioid-free anesthesia with lidocaine and esketamine versus balanced anesthesia with sufentanil for gynecological endoscopic surgery: a randomized controlled trial. Sci Rep. 2024;14(1):11759.","journal-title":"Sci Rep."}],"container-title":["Patient Safety in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13037-024-00408-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13037-024-00408-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13037-024-00408-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T18:12:21Z","timestamp":1722363141000},"score":1,"resource":{"primary":{"URL":"https:\/\/pssjournal.biomedcentral.com\/articles\/10.1186\/s13037-024-00408-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,30]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["408"],"URL":"https:\/\/doi.org\/10.1186\/s13037-024-00408-w","relation":{},"ISSN":["1754-9493"],"issn-type":[{"value":"1754-9493","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,30]]},"assertion":[{"value":"6 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics committee approval was not needed because no data were collected at the patient or health professional level.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}